Zen-O is designed to enable patients with respiratory disorders to better manage their oxygen therapy within and outside their homes. With the implementation of the ThingWorx platform, GCS says patients, clinicians and service providers will be able to closely monitor the data they need, when they need it. For instance, clinicians will be able to remotely monitor the device’s performance against a patient’s requirements.
“The application requires a level of integrity and legislative conformance, which we have built to give our customers confidence that this life-enhancing connected product will work securely,” said Gareth Pemberton, director of Innovation at GCE Group. “We are managing to move from concept to customer in a fraction of the time compared to other development routes by using a proven, robust and scalable platform.”
ThingWorx is comprised of a rapid application development platform, connectivity, machine learning capabilities, augmented reality, and integration with leading device clouds. These capabilities combine to deliver a comprehensive IoT technology stack that enables companies to securely connect products, quickly create applications, and innovate new ways to capture value.
To deliver the solution, InVMA - a ThingWorx partner - is engaged with Stream Technology for global communication provision, Device Authority for advanced, policy driven IoT security automation including authentication and certificate management, and also CoCom, a UK based Intel hardware development house.
“ThingWorx will enable the GCE Group to produce smart devices that provide patients more flexibility and freedom than traditional products,” said David Grammer, vice president, northern Europe, PTC. “Their deployment of the ThingWorx platform underscores the value of rapid application development, connectivity and analytics capabilities in products.”
